The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension

Hypertension

Volumn 59, Issue 3, 2012, Pages 555-557

  Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; PLACENTAL GROWTH FACTOR; RENIN; URIC ACID; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

CHRONIC DISEASE; FALSE POSITIVE RESULT; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTENSION; MATERNAL HYPERTENSION; NOTE; PLASMA RENIN ACTIVITY; PREDICTION; PREECLAMPSIA; PREECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ANGIOGENESIS INDUCING AGENTS; BLOOD PRESSURE; CALCIUM CARBONATE; FEMALE; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY;

EID: 84857632504     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.184192     Document Type: Note

References (11)

1. Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [see comment]. Am J Obstet Gynecol. 2000;183:S1-S22.
2. August P, Helseth G, Cook EF, Sison C. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol. 2004;191:1666-1672. (Pubitemid 39491195)
3. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MVC, Martins-Costa Sr, Bartz J, de Barros Santos C, Cecatti JG, Costa R, Ramos JG, Spinnato Ii JA. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol. 2008;199:268.e261-268.e269.
4. Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, August P. Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension. 2012;59:740-746.
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [see comment]. J Clin Invest. 2003;111: 649-658. (Pubitemid 36278583)
6. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642-649. (Pubitemid 43865232)
7. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109: 168-180. (Pubitemid 46035522)
8. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008;112:359-372.
9. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, Group CS. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005. (Pubitemid 44343543)
10. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-1204. (Pubitemid 20007682)
11. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190:1464-1466. (Pubitemid 38692249)